Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FreeRoss Announces a 1/4 Million Signers in Support of Ross Ulbricht's Clemency
  • USA - English

Momentum is growing to seek clemency for first-time offender Ross Ulbricht who was sentenced to double life plus 40 years for all nonviolent charges.


News provided by

FreeRoss.org

Jan 30, 2020, 07:00 ET

Share this article

Share toX

Share this article

Share toX

TUCSON, Ariz., Jan. 30, 2020 /PRNewswire-PRWeb/ -- FreeRoss.org: A wave of momentum is underway to free Ross Ulbricht from a double life plus forty-year sentence. The FreeRoss team, a dedicated group of loved ones and supporters spearheaded by mother Lyn Ulbricht, has worked tirelessly to raise awareness and build support for clemency. After close to seven years in prison, they believe Ulbricht, a nonviolent first-time offender, deserves a second chance.

A clemency petition (https://change.org/FreeRossNow) launched on the community-driven Change.org website has to date gathered over a quarter million signatures. The petition, addressed to President Trump, is currently the second largest clemency petition on the site. In addition, Ulbricht's supporters across the country have been attending Donald Trump rallies with signs and fliers, asking the president to commute the sentence.

FreeRoss.org features an impressive collection of over 160 organizations, leaders and figures from across the political spectrum who have voiced support. These include Governor Gary Johnson, Sister Helen Prejean, Noam Chomsky, and the Libertarian Party, which unanimously passed a resolution in 2018 asking the president to issue clemency to Ulbricht.

Other supporters include well-known Conservative and Trump ally Charlie Kirk, founder of Turning Point USA, who shared with his 1.5 million Twitter followers: "The more I learn about Ross Ulbricht and his over-prosecution the more outraged I am about this total miscarriage of justice." Last month, Tim Draper, one of the world's most successful investors, said during an interview: "Free Ross! Why put these really extraordinary people in jail? We need entrepreneurs like that guy…We need their energy and their minds and their force…I'm sure he's done enough time. Get him out!"

Ross Ulbricht's all nonviolent convictions stem from an e-commerce website he created while in his mid-twenties. Ulbricht was a libertarian and firm believer in personal freedom and privacy. Despite what some media reported, Silk Road was not created as a drug marketplace, but rather as a free market based on the libertarian non-aggression principle. Using then-little-known Bitcoin as currency, users could buy and sell both legal and illegal items as long as no third party was harmed. The site prohibited pedophilia, violent listings, and anything that could "harm or defraud" others. However, the site's anonymity attracted many drug sales (most commonly marijuana according to a Carnegie Mellon study). Ulbricht was not prosecuted for causing harm or bodily injury, or for selling illegal items himself. Rather, he was held responsible for what others sold on the site. His sentence dwarfs that of all other defendants with similar charges, including Blake Benthall, arrested as one of the two men behind the larger copycat Silk Road 2.0, who only spent 13 days in jail.

In 2018, Law Enforcement Action Partnership (LEAP), National Lawyers Guild (NLG), Cato Institute, Reason Foundation, and 16 other eminent organizations filed five amicus briefs in support of Ross Ulbricht's Supreme Court petition (https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/html/public/17-950.html). They challenged important Fourth and Sixth Amendment violations during Ross Ulbricht's investigation and sentencing and expressed serious concerns over the excessive sentence imposed by District Judge Katherine Forrest. The Supreme Court declined to hear the case, ending Ulbricht's direct appeals.

Since then, the FreeRoss team has focused on gaining clemency for Ulbricht from the president. Lyn Ulbricht said: "We are grateful that more and more people have come to realize that Ross was not treated fairly. The punishment doesn't fit the crime. Ross's case was riddled with corruption and abuse, and some in the mainstream media smeared him with unprosecuted allegations and other falsehoods. We hope the president will see fit to commute Ross's sentence to time served. He has been punished enough for a first-time offense."

Ulbricht has taken responsibility for his mistakes and been a role model in prison while helping fellow prisoners by tutoring and teaching classes.

Many online sources contain sensationalized, inaccurate information about Ross Ulbricht and the Silk Road case. The FreeRoss team has assembled comprehensive, reliable and documented material at https://FreeRoss.org.

SOURCE FreeRoss.org

Modal title

Sign Ross's clemency petition at FreeRoss.org/petition
Sign Ross's clemency petition at FreeRoss.org/petition
Visit FreeRoss.org
Visit FreeRoss.org
Sign Ross's clemency petition at FreeRoss.org/petition Visit FreeRoss.org

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.